Status:
COMPLETED
Anaerobic Power and Salbutamol
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Natural Sciences and Engineering Research Council, Canada
Conditions:
Ergogenic Athletic Performance
Eligibility:
All Genders
19-40 years
Phase:
NA
Brief Summary
Athletes using inhaled β2-adrenoreceptor agonists (IBAs) win a disproportionate number of medals. However, most previous research has shown that β2 agonists do not improve exercise performance in eith...
Eligibility Criteria
Inclusion
- maximal oxygen consumption of ≥60 and ≥55 mL⋅kg-1⋅min-1 or ≥5⋅L⋅min-1 and ≥4⋅L⋅min-1 for men and women
Exclusion
- pregnant women
- any history of uncontrolled respiratory or cardiac disease
- smokers
- diabetics
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02255630
Start Date
January 1 2015
End Date
August 1 2016
Last Update
November 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia, Environmental Physiology Laboratory
Vancouver, British Columbia, Canada, V6T 1Z1